全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

为什么选择我们？ >>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎

Breast Cancer Research

ISSN Print: 1465-5411

ISSN Online:

主页: http://breast-cancer-research.com

分享:




Go

How much can improved molecular and pathologic discriminants change local therapy?

Monica Morrow

Mechanisms of metastasis

Kent W Hunter, Nigel PS Crawford, Jude Alsarraj

Should lifestyle modifications be promoted to prevent breast cancer?

Anthony Howell, Michelle Harvie

Assessing individual risk for breast cancer: role of oestrogens and androgens

Richard J Santen

Introduction to sessions on 'Predicting personal risk for breast cancer'

Mitch Dowsett

Psychosocial aspects of risk appraisal

Lesley Fallowfield

Assessing risk for breast cancer

Jack Cuzick

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

Mollie H Wright, Anna Calcagno, Crystal D Salcido, Marisa D Carlson, Suresh V Ambudkar, Lyuba Varticovski

Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo

Ji-Young Jang, Yun Choi, Yoon-Kyung Jeon, Chul-Woo Kim

Breast cancer stroma frequently recruits fetal derived cells during pregnancy

Gil Dubernard, Sélim Aractingi, Michel Oster, Roman Rouzier, Marie-Christine Mathieu, Serge Uzan, Kiarash Khosrotehrani

1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p'-DDE) disrupts the estrogen-androgen balance regulating the growth of hormone-dependent breast cancer cells

Michel Aubé, Christian Larochelle, Pierre Ayotte

BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype

Cameron Snell, Michael Krypuy, Ee Wong, kConFab investigators, Maurice B Loughrey, Alexander Dobrovic

Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study

Vanessa Dumeaux, Anne-Lise B？rresen-Dale, Jan-Ole Frantzen, Merethe Kumle, Vessela N Kristensen, Eiliv Lund

ZNF366 is a novel corepressor for estrogen receptor alpha that mediates its effects through interaction with CtBP

S Ali, M Periyasamy, J Lopez-Garcia, RS Thomas, M Christian, MG Parker, L Buluwela

Breast cancer subtypes and survival in patients with brain metastases

Byung-Ho Nam, Sun Kim, Hye-Sook Han, Youngmee Kwon, Keun Lee, Tae Kim, Jungsil Ro

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families

Hannaleena Eerola, Mira Heinonen, P？ivi Heikkil？, Outi Kilpivaara, Anitta Tamminen, Kristiina Aittom？ki, Carl Blomqvist, Ari Ristim？ki, Heli Nevanlinna

Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model

Stephan Woditschka, Jill D Haag, Bob Mau, Ronald A Lubet, Michael N Gould

Loss of oestrogen receptor alpha in long-term antioestrogen-resistant cells: reversal by a c-src inhibitor

A Bensmail, I Hutcheson, M Giles, J Gee, R Nicholson

Dietary patterns across the life course, mammographic density and implications for breast cancer: results from a British prospective cohort

G Mishra, I dos Santos Silva, S McNaughton, V McCormack, R Hardy, A Stephen, D Kuh

Two functionally distinct epithelial progenitors exist within the luminal cell compartment of the mouse mammary gland

J Stingl, CJ Eaves, CJ Watson

Suppression of the NF-κB cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis

A Wakefield, L Piggott, D Croston, WG Jiang, R Clarkson

RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours

WN Cooper, RE Dickinson, A Dallol, LB Hesson, I Bieche, GJ Clark, ER Maher, ER Zabarovsky, F Latif

Topoisomerase II expression as a determinant of chromosomal radiosensitivity and possible susceptibility in breast cancer

PE Bryant, AC Riches, S Terry, O Shovman, D Adamson

Role of poly(ADPribosyl)ation of CTCF in cancer and normal breast cells

F Docquier, G Kita, D Farrar, I Chernukhin, E Klenova

Molecular imaging as a tool for translating breast cancer science

David A Mankoff

Use of BRCA1 protein:protein interactions to classify cancer risk

JR Morris, SV Tavtigian

Activation of TGF-beta signalling in breast cancer metastatic cells

S Giampieri, E Sahai

Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes

S Wilkie, G Picco, J Foster, D Davies, S Julien, L Cooper, S Arif, S Mather, J Taylor-Papadimitriou, J Burchell, J Maher

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients

Tanja Fehm, Natalia Krawczyk, Erich-Franz Solomayer, Graziella Becker-Pergola, Silke Dürr-St？rzer, Hans Neubauer, Harald Seeger, Annette Staebler, Diethelm Wallwiener, Sven Becker

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study

Flavia Novelli, Michele Milella, Elisa Melucci, Anna Di Benedetto, Isabella Sperduti, Raffaele Perrone-Donnorso, Letizia Perracchio, Irene Venturo, Cecilia Nisticò, Alessandra Fabi, Simonetta Buglioni, Pier Natali, Marcella Mottolese

The evolving role of oestrogen receptor beta in clinical breast cancer

Valerie Speirs

Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice

Karen A Dunphy, Anneke C Blackburn, Haoheng Yan, Lauren R O'Connell, D Joseph Jerry

Autoantibodies as potential biomarkers for breast cancer

Li Zhong, Kun Ge, Jin-chi Zu, Long-hua Zhao, Wei-ke Shen, Jian-fei Wang, Xiao-gang Zhang, Xu Gao, Wanping Hu, Yun Yen, Kemp H Kernstine

Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study

Caroline Diorio, Jacques Brisson, Sylvie Bérubé, Michael Pollak

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors

Eiji Sunami, Masaru Shinozaki, Myung-Shin Sim, Sandy L Nguyen, Anh-Thu Vu, Armando E Giuliano, Dave SB Hoon

Breast cancer stem cell markers – the rocky road to clinical applications

Gabriela Dontu

Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study

Thomas P Ahern, Timothy L Lash, Henrik T S？rensen, Lars Pedersen

Highway to heaven: mammary gland development and differentiation

Lorenzo Melchor, Matthew J Smalley

On the way to specifically targeting minimal residual disease?

Gerhard Gebauer

Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer

Charles Swanton, Zoltan Szallasi, James D Brenton, Julian Downward

Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models

Christina N Bennett, Jeffrey E Green

Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer

Signe Borgquist, Annika J？gi, Fredrik Pontén, Lisa Rydén, Donal J Brennan, Karin Jirstr？m

Targeting aspartate aminotransferase in breast cancer

Joshua Thornburg, Kristin K Nelson, Brian F Clem, Andrew N Lane, Sengodagounder Arumugam, Allan Simmons, John W Eaton, Sucheta Telang, Jason Chesney

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

Golareh Habibi, Samuel Leung, Jennifer H Law, Karen Gelmon, Hamid Masoudi, Dmitry Turbin, Michael Pollak, Torsten O Nielsen, David Huntsman, Sandra E Dunn

Alternative splicing and the progesterone receptor in breast cancer

David MW Cork, Thomas WJ Lennard, Alison J Tyson-Capper

Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism

Vasilis Androutsopoulos, Randolph RJ Arroo, John F Hall, Somchaiya Surichan, Gerry A Potter

Mammographic density. Measurement of mammographic density

Martin J Yaffe

Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?

Graham B Byrnes, Melissa C Southey, John L Hopper

Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study

Lena U Rosenberg, Fredrik Granath, Paul W Dickman, Kristjana Einarsdóttir, Sara Wedrén, Ingemar Persson, Per Hall

The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas

Jason I Herschkowitz, Xiaping He, Cheng Fan, Charles M Perou

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705